GLOO vs PATH vs EGAN Stock Comparison

Gloo Holdings, UiPath and Egain Prices as of Oct 26, 2026 Peers: Industry group
1 more company in this comparison (APPN) Create a free account to keep reading and compare up to 10 companies.
GLOO Gloo Holdings, Inc.
$2.92 -38.8% 1M
Market cap
$237.30M
P/E
–
Revenue (TTM)
$154.29M
Div. yield
–
Business Process Automation Technology
1 win
PATH UiPath, Inc.
$14.28 +14.5% 1M -13.3% 1Y
Market cap
$7.27B
P/E
20.1x
Revenue (TTM)
$1.72B
Div. yield
–
Business Process Automation Technology
5 wins
EGAN EGAIN Corp
$5.59 -4.1% 1M -61.3% 1Y
Market cap
$153.99M
P/E
17.1x
Revenue (TTM)
—
Div. yield
–
Business Process Automation Technology
3 wins

Head to Head

9 decided of 12

UiPath leads on 5 of the 12 questions below (UiPath 5, Egain 3, Gloo Holdings 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionGLOOPATHEGANLeader
Larger companyMarket capitalisation $237.30M $7.27B $153.99M PATH
Cheaper on earningsLower P/E, profitable companies only -1.9x 20.1x 17.1x EGAN
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 18.8x 111.8x PATH
Faster revenue growthRevenue growth, trailing twelve months +275.5% +15.0% — GLOO
More profitableNet margin, trailing twelve months -81.3% 21.0% — PATH
Better return on capitalReturn on invested capital -54.6% — — –
Less leveragedLower net debt / EBITDA 0.0x — — –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months — -13.3% -61.3% PATH
Better 5-year returnAnnualised price return, 5 years — -22.5%/yr -11.6%/yr EGAN
Less volatileAnnualised volatility, 1 year 89.4% 64.5% 60.8% EGAN
Higher overall scoreMean of the five percentile scores vs peers 36/100 77/100 — PATH

Percentile Scorecard

GLOOPATHEGAN

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisGLOOPATHEGAN
Valuation 19 #83 of 102 78 #23 of 102 96 #5 of 102
Growth 85 #16 of 98 87 #14 of 98 –
Profitability 14 #82 of 95 76 #24 of 95 –
Financial Health 58 #46 of 109 89 #13 of 109 79 #24 of 109
Shareholder Returns 5 #61 of 64 54 #30 of 64 –
Overall 36 77 –
  • GLOO ranked among 115 companies in Business Applications
  • PATH ranked among 115 companies in Business Applications
  • EGAN ranked among 115 companies in Business Applications

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodGLOOPATHEGANSPY
1 month -38.8%+14.5%-4.1% -0.8%
3 months -10.2%+23.0%-17.9% +3.5%
6 months -56.0%+36.5%-26.7% +7.0%
Year to date -48.7%-12.9%-45.7% +12.2%
1 year —-13.3%-61.3% +13.0%
3 years —-4.4%-3.8% +86.3%
3 years, per year —-1.5%-1.3% +23.1%
5 years —-72.1%-46.1% +68.6%
5 years, per year —-22.5%-11.6% +11.0%
10 years ——+96.1% +258.0%
10 years, per year ——+7.0% +13.6%

Risk

MeasureGLOOPATHEGANSPY
Volatility, 1Y 89.4%64.5%60.8% 12.7%
Downside volatility, 1Y 84.1%66.0%71.3% 12.7%
Beta vs S&P 500, 1Y 0.871.051.70 1.00
Return / volatility, 1Y —-0.21-1.01 1.02
Max drawdown, 5Y -69.3%-83.7%-66.9% -25.4%
From 52-week high -69.3%-26.0%-63.8% -1.8%
52-week high $9.50$19.29$15.46 $779.14
52-week low $2.92$9.38$5.11 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleGLOOPATHEGAN
P/E now vs peer median -1.9xmedian 28.8x 20.5xmedian 28.8x 17.1xmedian 28.8x
P/S now vs peer median 1.5xmedian 2.8x 3.8xmedian 2.8x 1.6xmedian 2.8x
EV/EBITDA now vs peer median -2.8xmedian 17.7x 17.7xmedian 17.7x —median 17.7x
P/FCF now vs peer median -3.6xmedian 15.8x 18.0xmedian 15.8x 7.1xmedian 15.8x
P/B now vs peer median 1.5xmedian 3.2x 3.3xmedian 3.2x 1.7xmedian 3.2x
PEG now vs peer median —median 0.85 0.33median 0.85 —median 0.85

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsGLOOPATHEGAN
Revenue $154.29M $1.72B –
Gross profit $45.81M $1.42B –
Operating income -$100.96M $152.95M –
Net income -$125.92M $361.92M –
Free cash flow -$66.32M $362.96M –
R&D $24.02M $368.32M –
EPS (diluted) $-1.54 $0.69 –
Cash & equivalents $39.30M $607.41M $73.34M
Total debt $37.42M – –
Shares (diluted) 81.41M 523.01M 27.86M
Enterprise value $92.56M $1.81B -$136.22M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricGLOOPATHEGAN
P/E -1.9x 20.5x 17.1x
P/FCF -3.6x 18.0x 7.1x
P/Operating cash flow -3.7x 17.5x –
P/S 1.5x 3.8x 1.6x
P/B 1.5x 3.3x 1.7x
P/Tangible book 2.0x 3.5x 1.7x
EV/EBITDA -2.8x 17.7x –
EV/EBIT -2.3x 34.2x –
EV/Revenue 1.5x 3.0x –
EV/FCF -3.6x 14.4x –
EV/Operating cash flow -3.7x 14.0x –
PEG (3Y EPS CAGR) – 0.33 –

Growth

14 metrics
MetricGLOOPATHEGAN
Revenue growth (1Y) 275.5% 15.0% –
Revenue CAGR (3Y) – 14.4% –
Gross profit growth (1Y) 368.8% 14.6% –
Gross profit CAGR (3Y) – 13.8% –
Operating income growth (1Y) 1.8% 430.0% –
Operating income CAGR (3Y) – 38.3% –
Net income growth (1Y) 2.7% 1,695% –
Net income CAGR (3Y) – 59.2% –
EPS growth (1Y) 91.1% 1,763% –
EPS CAGR (3Y) – 61.2% –
Operating cash flow growth (1Y) – 11.5% –
Operating cash flow CAGR (3Y) – 27.9% –
Free cash flow growth (1Y) – 17.2% –
Free cash flow CAGR (3Y) – 29.3% –

Profitability

14 metrics
MetricGLOOPATHEGAN
Gross margin 29.7% 82.6% –
EBITDA margin -55.4% 17.2% –
Operating margin -65.4% 8.9% –
Pretax margin -83.9% 12.3% –
Net margin -81.3% 21.0% –
FCF margin -43.0% 21.1% –
Operating cash flow margin -41.7% 21.7% –
Return on equity -84.9% 18.8% –
Return on assets -49.4% 12.5% –
Return on invested capital -54.6% – –
Return on capital employed -50.5% 7.3% –
Asset turnover 0.6x 0.6x –
Cash conversion (OCF / net income) 0.5x 1.0x –
Stock comp / revenue 12.3% 13.6% –

Financial Health

11 metrics
MetricGLOOPATHEGAN
Debt / assets 13.8% – –
Debt / equity 0.2x – –
Net debt / EBITDA 0.0x – –
Debt / FCF -0.6x – –
Liabilities / assets 42.5% 33.0% 43.1%
Equity / assets 57.5% 67.0% 56.9%
Interest coverage -9.9x – –
Current ratio 1.2x 2.4x 1.7x
Quick ratio 1.1x 2.1x 1.7x
Cash ratio 0.7x 1.6x 1.2x
Altman Z-score 0.23 4.51 –

Shareholder Returns

7 metrics
MetricGLOOPATHEGAN
Dividend yield – – –
Net buyback yield -37.7% 3.9% –
Shareholder yield -37.7% 3.9% –
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusGLOOPATHEGAN
Forward P/E – 18.8xFY2026 111.8xFY2027
EPS, next fiscal year $-0.60FY2026 $0.76FY2026 $0.05FY2027
EPS growth, next FY – +5.6%FY2026 -89.4%FY2027
EPS growth, the year after – +14.5% -60.0%
Revenue, next fiscal year $188.99MFY2026 $1.87BFY2026 $89.04MFY2027
Revenue growth, next FY +99.7%FY2026 +16.3%FY2026 -2.3%FY2027
Revenue growth, the year after +56.5% -3.3% -12.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersGLOOPATHEGAN
Held by institutions – 79.0% 53.0%
Institutions holding – 525 106
Change in shares held, QoQ – +14.3% -1.1%
Institutions buying – 276 55
Institutions selling – 169 34
Buyers to sellers – 1.63 1.62

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

GLOOPATHEGAN
GLOO 1.00 0.05 0.14
PATH 0.05 1.00 0.41
EGAN 0.14 0.41 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, GLOO, PATH and EGAN?

UiPath (PATH) is the largest by market capitalisation: Gloo Holdings (GLOO) $237.30M, UiPath (PATH) $7.27B, Egain (EGAN) $153.99M.

Which stock is cheaper, GLOO, PATH and EGAN?

Egain (EGAN) trades on the lowest price-to-earnings ratio (Gloo Holdings (GLOO) -1.9x, UiPath (PATH) 20.1x, Egain (EGAN) 17.1x). On next year's consensus earnings, UiPath (PATH) is cheapest (UiPath (PATH) 18.8x, Egain (EGAN) 111.8x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Gloo Holdings (GLOO) grew revenue fastest over the trailing twelve months: Gloo Holdings (GLOO) +275.5%, UiPath (PATH) +15.0%.

Which company is more profitable?

UiPath (PATH) has the highest net margin (Gloo Holdings (GLOO) -81.3%, UiPath (PATH) 21.0%).

Which stock has performed better?

Over the past year UiPath (PATH) returned the most: UiPath (PATH) -13.3%, Egain (EGAN) -61.3%. Over five years, Egain (EGAN) compounded fastest (UiPath (PATH) -22.5%/yr, Egain (EGAN) -11.6%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Egain (EGAN) has been the steadiest (Gloo Holdings (GLOO) 89.4%, UiPath (PATH) 64.5%, Egain (EGAN) 60.8%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, GLOO, PATH and EGAN?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, UiPath (PATH) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.